Author: InCred Money

March 2026. Semaglutide, the molecule behind Ozempic and Wegovy, the weight-loss drug, loses its

In 1988, Jim Simons started a quantitative hedge fund called Renaissance Technologies. He wasn’t

There’s a pattern that has repeated itself across every financial market, every decade, every

India’s semiconductor story has, in many ways, been a story of a lost decade

Last week’s market reaction said more about our fears than about technology itself. News

Imagine winning a massive lottery jackpot tomorrow. Millions of dollars land in your bank

If you’ve been glancing at the quarterly results of India’s corporate giants, especially the

At the start of 2025, I wrote about how the year was already looking

We like simple answers to complex questions and GDP is one such answer. Over

Happy New Year! Every new year comes with a quiet optimism, the belief that